• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定的 PTPRC/CD45 磷酸化事件受干细胞趋化因子 CXCL12 调控,调节原始造血细胞的迁移。

A specific PTPRC/CD45 phosphorylation event governed by stem cell chemokine CXCL12 regulates primitive hematopoietic cell motility.

机构信息

Stem Cell and Leukaemia Proteomics Laboratory, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, University of Manchester, 27 Palatine Rd, Manchester, M20 4QL;

出版信息

Mol Cell Proteomics. 2013 Nov;12(11):3319-29. doi: 10.1074/mcp.M112.024604. Epub 2013 Sep 1.

DOI:10.1074/mcp.M112.024604
PMID:23997015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3820942/
Abstract

CXCL12 governs cellular motility, a process deregulated by hematopoietic stem cell oncogenes such as p210-BCR-ABL. A phosphoproteomics approach to the analysis of a hematopoietic progenitor cell line treated with CXCL12 and the Rac 1 and 2 inhibitor NSC23766 has been employed to objectively discover novel mechanisms for regulation of stem cells in normal and malignant hematopoiesis. The proteomic data sets identified new aspects of CXCL12-mediated signaling and novel features of stem cell regulation. We also identified a novel phosphorylation event in hematopoietic progenitor cells that correlated with motile response and governed by the chemotactic factor CXCL12. The novel phosphorylation site on PTPRC/CD45; a protein tyrosine phosphatase, was validated by raising an antibody to the site and also using a mass spectrometry absolute quantification strategy. Site directed mutagenesis and inhibitor studies demonstrated that this single phosphorylation site governs hematopoietic progenitor cell and lymphoid cell motility, lies downstream from Rac proteins and potentiates Src signaling. We have also demonstrated that PTPRC/CD45 is down-regulated in leukemogenic tyrosine kinase expressing cells. The use of discovery proteomics has enabled further understanding of the regulation of PTPRC/CD45 and its important role in cellular motility in progenitor cells.

摘要

CXCL12 调节细胞运动,这一过程被造血干细胞癌基因(如 p210-BCR-ABL)失调。采用磷酸化蛋白质组学方法分析经 CXCL12 和 Rac1 和 2 抑制剂 NSC23766 处理的造血祖细胞系,客观地发现了调节正常和恶性造血中干细胞的新机制。蛋白质组数据集确定了 CXCL12 介导的信号转导的新方面和干细胞调节的新特征。我们还在造血祖细胞中发现了一个与运动反应相关的新磷酸化事件,该事件受趋化因子 CXCL12 调节。在一种蛋白酪氨酸磷酸酶 PTPRC/CD45 上发现了一个新的磷酸化位点,该位点通过针对该位点的抗体和使用质谱绝对定量策略进行了验证。定点突变和抑制剂研究表明,这个单一的磷酸化位点调节造血祖细胞和淋巴样细胞的运动,位于 Rac 蛋白的下游,并增强了Src 信号。我们还证明,PTPRC/CD45 在表达致癌酪氨酸激酶的白血病细胞中下调。发现蛋白质组学的应用使我们进一步了解了 PTPRC/CD45 的调节及其在祖细胞中细胞运动中的重要作用。

相似文献

1
A specific PTPRC/CD45 phosphorylation event governed by stem cell chemokine CXCL12 regulates primitive hematopoietic cell motility.特定的 PTPRC/CD45 磷酸化事件受干细胞趋化因子 CXCL12 调控,调节原始造血细胞的迁移。
Mol Cell Proteomics. 2013 Nov;12(11):3319-29. doi: 10.1074/mcp.M112.024604. Epub 2013 Sep 1.
2
p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression.p210BCR-ABL通过改变CXCR4信号传导和下调CXCR4表达来抑制SDF-1趋化反应。
Cancer Res. 2005 Apr 1;65(7):2676-83. doi: 10.1158/0008-5472.CAN-04-2152.
3
CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules.CD45调节造血祖细胞的滞留、运动性和数量,并影响干骺端小梁的破骨细胞重塑。
J Exp Med. 2008 Sep 29;205(10):2381-95. doi: 10.1084/jem.20080072. Epub 2008 Sep 8.
4
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.一种新型的含SH2结构域的磷脂酰肌醇3,4,5-三磷酸5-磷酸酶(SHIP2)在慢性粒细胞白血病祖细胞中持续发生酪氨酸磷酸化,并与src同源和胶原蛋白基因(SHC)相关联。
Blood. 1999 Apr 15;93(8):2707-20.
5
AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells.AHI-1与BCR-ABL相互作用,并调节BCR-ABL的转化活性以及慢性粒细胞白血病干/祖细胞对伊马替尼的反应。
J Exp Med. 2008 Oct 27;205(11):2657-71. doi: 10.1084/jem.20072316. Epub 2008 Oct 20.
6
p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.p210(Bcr-Abl)使慢性髓性白血病细胞中Cdc42 GTP酶信号对SDF-1α导向的迁移脱敏。
Oncogene. 2009 Nov 19;28(46):4105-15. doi: 10.1038/onc.2009.260. Epub 2009 Aug 31.
7
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.靶向 GSK3β 可促进静止期 CD34+ 慢性髓性白血病祖细胞中伊马替尼介导的细胞凋亡,同时保留正常干细胞。
Blood. 2012 Mar 8;119(10):2335-45. doi: 10.1182/blood-2011-06-361261. Epub 2012 Jan 18.
8
Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.间质龛特异性表达 Cxcl12 控制治疗抵抗性白血病干细胞的静止状态。
Cell Stem Cell. 2019 May 2;24(5):769-784.e6. doi: 10.1016/j.stem.2019.02.018. Epub 2019 Mar 21.
9
Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells.人类白血病细胞中通过Src家族激酶介导的BCR/ABL癌蛋白与CXCR4信号通路之间的串扰。
J Exp Med. 2002 Sep 2;196(5):667-78. doi: 10.1084/jem.20020519.
10
Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo.Rac2 GTPase 缺陷在体内耗尽 BCR-ABL+白血病干细胞和祖细胞。
Blood. 2010 Jul 8;116(1):81-4. doi: 10.1182/blood-2009-10-247437. Epub 2010 Apr 20.

引用本文的文献

1
Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse models.造血干细胞和祖细胞在小鼠模型中赋予交叉保护性训练免疫。
iScience. 2023 Aug 9;26(9):107596. doi: 10.1016/j.isci.2023.107596. eCollection 2023 Sep 15.
2
Identification of prognostic hub genes and therapeutic targets for selenium deficiency in chicks model through transcriptome profiling.通过转录组谱分析鉴定雏鸡模型中硒缺乏症的预后关键基因和治疗靶点。
Sci Rep. 2023 May 29;13(1):8695. doi: 10.1038/s41598-023-34955-6.
3
Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.眼内液药代动力学研究抗血管生成糖蛋白 Opticin。
Mol Pharm. 2020 Jul 6;17(7):2390-2397. doi: 10.1021/acs.molpharmaceut.0c00151. Epub 2020 Jun 9.
4
Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.人肾透明细胞癌关键基因和通路的生物信息学与功能分析
Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473. Epub 2018 Apr 12.
5
Genotoxic stress induces Sca-1-expressing metastatic mammary cancer cells.遗传毒性应激诱导 Sca-1 表达的转移性乳腺癌细胞。
Mol Oncol. 2018 Aug;12(8):1249-1263. doi: 10.1002/1878-0261.12321. Epub 2018 Jun 13.
6
Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature.靶向癌症干细胞的化学蛋白质组学方法:当前文献综述
Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):315-327. doi: 10.21873/cgp.20042.
7
Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.对JAK2V617F诱导变化的蛋白质组学分析确定了潜在的新联合治疗方法。
Leukemia. 2017 Dec;31(12):2717-2725. doi: 10.1038/leu.2017.143. Epub 2017 May 23.
8
ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.使用纳米毛细管等电聚焦技术检测肺癌和肺气肿中的 ERK 和 AKT 磷酸化状态。
BMJ Open Respir Res. 2016 Feb 17;3(1):e000114. doi: 10.1136/bmjresp-2015-000114. eCollection 2016.
9
Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics.毛细管纳米免疫分析:推动定量蛋白质组学分析、生物标志物评估和分子诊断
J Transl Med. 2015 Jun 6;13:182. doi: 10.1186/s12967-015-0537-6.
10
c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells.c-Myc在人肝癌细胞中TADs诱导的细胞凋亡和细胞周期停滞中起关键作用。
Am J Cancer Res. 2015 Feb 15;5(3):1076-88. eCollection 2015.

本文引用的文献

1
A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5.从白血病致癌基因和干细胞趋化因子到通过 THOC5 进行 RNA 加工的途径。
Leukemia. 2013 Apr;27(4):932-40. doi: 10.1038/leu.2012.283. Epub 2012 Oct 3.
2
Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation.鉴定受翻译后调控的六种致白血病酪氨酸激酶的核蛋白靶标。
PLoS One. 2012;7(6):e38928. doi: 10.1371/journal.pone.0038928. Epub 2012 Jun 22.
3
BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response.BCR/ABL 调节与依托泊苷诱导的 DNA 损伤反应相关的蛋白磷酸化。
J Proteomics. 2012 Dec 21;77:14-26. doi: 10.1016/j.jprot.2012.06.003. Epub 2012 Jun 15.
4
The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells.Src 家族激酶抑制剂 PP2 和 PP1 可有效阻断 TGF-β1 诱导的已建立和原代癌细胞的迁移和侵袭。
Cancer Chemother Pharmacol. 2012 Aug;70(2):221-30. doi: 10.1007/s00280-012-1904-0. Epub 2012 Jun 15.
5
Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.酪氨酸激酶抑制剂作为治疗 B 细胞淋巴瘤和自身免疫性疾病的潜在药物。
Expert Opin Investig Drugs. 2012 Jul;21(7):921-47. doi: 10.1517/13543784.2012.685650. Epub 2012 May 22.
6
CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice.CD45 调节未成熟正常和白血病人类细胞在移植免疫缺陷小鼠中的归巢和植入。
Exp Hematol. 2011 Dec;39(12):1161-1170.e1. doi: 10.1016/j.exphem.2011.08.012. Epub 2011 Sep 10.
7
RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.RAC2、AEP 和 ICAM1 的表达与小儿前 B 细胞急性淋巴细胞白血病小鼠模型中的中枢神经系统疾病相关。
Blood. 2011 Jul 21;118(3):638-49. doi: 10.1182/blood-2010-09-307330. Epub 2011 May 23.
8
Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells.鸟嘌呤核苷酸交换因子 Vav1 调节造血干细胞和祖细胞的血管周围归巢和骨髓滞留。
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9607-12. doi: 10.1073/pnas.1102018108. Epub 2011 May 23.
9
R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization.R-Ras 和 Rac GTPase 串扰调节造血祖细胞的迁移、归巢和动员。
J Biol Chem. 2011 Jul 8;286(27):24068-78. doi: 10.1074/jbc.M111.226951. Epub 2011 May 13.
10
Insights into the stem cells of chronic myeloid leukemia.慢性髓性白血病干细胞研究新视角。
Leukemia. 2010 Nov;24(11):1823-33. doi: 10.1038/leu.2010.159. Epub 2010 Sep 23.